Matt Bazzani

Pharma and healthcare pros, mark your calendars! 📅 Join #DIASanDiego2024 to hear top experts discuss the latest in drug info and healthcare. 🚀 Stay ahead in your field and network with industry leaders. Don’t miss this chance to elevate your career and knowledge. 🌟 . . . #DIA2024 #DIASANDIEGO #CancerTreatment #trendingreels #reels #viral #Clinicaltrials

4

Just one more week until #ASHPPharmacyFutures! Come stop by our booth and learn about how Loopback is helping health system specialty pharmacies #bridgethegap for better patient access. See you in Portland! #ASHP2024 #advancingpharmacyfuture #specialtypharmacy #patientcare #patientaccess #healthcareanalytics #dataanalytics #healthsystems #hospitals #specialtycare #improvingoutcomes #improvingaccess

14

💪 Boasting 25 FDA/CE-cleared indications, ADVATx stands as the gold standard for restoring dermal health — that also helps maximize your ROI 💰 ✅ ADVATx eliminates the need for costly consumables, keeping operating costs low ✅ ADVATx treats virtually all skin types, opening your practice up to a wider range of patients ✅ ADVATx provides off-the-table results to ensure return visits, providing the chance to explore further treatments 📸: @skinedit.steph, a thriving @reveal_lasers practice #advatx #yellowlaserenergy #skintransformation #yellowlasertreatment #beforeandafter #advatxtreatment #aestheticlaser *ADVATx is FDA-cleared for the treatment of inflammatory acne vulgaris, port-wine stains, telangiectasia on the face and legs, rosacea, hemangiomas, venous lakes, angiomas, scars, striae, warts, periocular and periorbital wrinkles, and psoriasis with the 589nm wavelength, and the treatment of fine lines and wrinkles, atrophic acne scars, and mild to moderate inflammatory acne with the 1319nm wavelength. ADVATx is CE-cleared for the treatment of telangiectasias, spider veins on the face and legs, rosacea, hemangiomas, port-wine stains, venous lakes, red or hypertrophic scars, melasma, hyperpigmentation, and skin rejuvenation with the 589nm wavelength, and the treatment of mild to moderate inflammatory acne vulgaris, the reduction of acne scars, pore size regulation and skin rejuvenation with the 1319nm wavelength.

30

See you in Seattle! We're thrilled to be attending the Association for Research in Vision and Ophthalmology (ARVO) conference and the FFB’s Annual Retinal Cell and Gene Therapy Innovation Summit in Seattle. Being at the forefront of retina research, understanding challenges, and building relationships are essential for patient-led organizations like ours to advance treatments. That’s why we prioritize attending these crucial events with our international USH1B partners, Save Sight Now Europe. Save Sight Now is an Usher syndrome research-driven organization. Over the last five years, our top priority has been to identify the world’s leading genomic and retinal specialists working on projects that can save the vision of those living with Usher syndrome Type 1B. We have partnered with the world's foremost IRD Foundation, the Foundation Fighting Blindness, built a robust and growing scientific advisory board, and cultivated enduring relationships with leading retina researchers, universities, and biotech companies. We understand the major obstacles to finding treatments and what’s necessary to pave the way for successful USH1B clinical trials. We've designed a holistic strategy and a comprehensive five-year roadmap — guided by the current research landscape — to direct our funding and decision-making. We fund the creation of cell and large animal models, support natural history studies (UNIRARE and Light4Deaf) for upcoming trials, and invest in new, emerging therapeutic strategies, all aimed at filling existing research gaps. If you’re in Seattle this week and next, please reach out—we’d love to connect! #UsherSyndrome #FundingResearch #RareDisease #MYO7A #USH1B

71

1 Comment

ICYMI: Unlocking the mystery of tender papules: What's causing this eruption? Stay tuned as we delve into the diagnosis. https://okt.to/wz2Ns9 #DermDX #SkinConditions #MedicalMystery #Derm #Dermatology #Dermatologist #DermInsights #SkincareExperts #DermDiaries #DermatologyExperts #Dermatology101 #DermatologyCare #DermatologyEducation

1

Tomorrow kicks off the American Society of Clinical Oncology (ASCO) Annual Meeting, where professionals working in #Oncology spend time connecting and collaborating. Find Corcept at Booth #14157 to learn more about the potential role of our proprietary selective #CortisolModulator in platinum-resistant ovarian cancer. #ASCO24 #OvarianCancer #ClinicalResearch #Phase3

105

May is Arthritis Awareness month. Arthritis impacts more than 53 million Americans, or 24% of adults. There are dozens of types of arthritis - the most common of which is osteoarthritis. Other varieties are rheumatoid arthritis, gout, and psoriatic arthritis. At Sage Infusion, we offer several treatment options for arthritis - including Actemra, Cimzia, Orencia, Remicade, Simponi Aria, and Skyrizi. View a full list of treatment options here: https://lnkd.in/g3cejiTt Calculate your costs: https://lnkd.in/eCxC5qiz #PatientCareReimagined #InfusionTherapy #InfusionCare #SageInfusion #ArthritisAwareness

7

#ISPOR2024 was a success – thanks to everyone who stopped by the Adelphi Values booth to check out our “Discrete Choice Experiment (DCE) Methodology Associated With a Multi-Phase Patient/Caregiver Preference Study in Growth Hormone Deficiency (GHD)” poster. Click below to see the results!   To learn more about Adelphi Research’s patient preference research capabilities, reach out to Graceanne Wayser or contact illuminate@adelphigroup.com.   #PatientPreference #MarketResearch #AdelphiResearch #AdelphiValues

32

Missed our March webinar, “Somatic Testing and Tumor Profiling Overview?” Catch the recording online! Listen as the University of Washington’s Eric Konnick, MD, MS, Angela Jacobson, MS, CGC, LGC, and Ankita Jhuraney, PhD, MS, PhD, talk about somatic testing, best practices for tumor profiling, and germline testing in #cancer. Watch it now: https://bit.ly/4bkAUUB Not an AONN+ member? We invite you to learn about all the valuable ways that we support you, your patients, and your community: https://bit.ly/3WnE5GI #genetics #genomics #nursenavigator #patientnavigator #patientnavigation #oncologynursenavigator #oncology #oncologynursing

16

US HCPs: MMA embolization with glue supported by #MIDWAY 43 tracking to sphenoid ridge to optimize vessel selection. Distal RRA snuffbox approach with #BENCHMARK071 support in RCC. Courtesy of Dr. Ben Yim and Dr. Ira Finch! Rx only. Risk: peninc.info/risk Clinical results may vary

49

US HCPs: MMA embolization with glue supported by #MIDWAY 43 tracking to sphenoid ridge to optimize vessel selection. Distal RRA snuffbox approach with #BENCHMARK071 support in RCC. Courtesy of Dr. Ben Yim and Dr. Ira Finch! Rx only. Risk: peninc.info/risk Clinical results may vary

83

The shift from FFS to Outcome Based Reimbursement is underway for healthcare. CWG can help you position your therapy to take advantage of it. #BIO2024. #SanDiego #Commercialization

1

Can you guess what this pink lesion on the palm is? 🤔 Learn about the diagnosis and its implications in our latest DERM DX case study. https://okt.to/XA8u0x #MedicalCase #SkinHealth #Derm #Dermatology #Dermatologist #DermInsights #SkincareExperts #DermDiaries #DermatologyExperts #Dermatology101 #DermatologyCare #DermatologyEducation

4

2 Comments

#ICYMI: Last month we announced that we raised $132.5 million in an oversubscribed #SeriesC financing to advance our pipeline of potential therapies for fibrotic lung diseases and oncology. We are thankful for the support of our investors, board, #biotech community and the entire Endeavor BioMedicines team.     In this BioSpace article, get more details about what this financing means for the future of our pipeline and our goal to restore hope for patients with life-threatening diseases: https://bit.ly/4aVqAmo    #biotechnews #fundraising #venturecapital #oncology #lungdiseases

51

Field Medical teams are the interface between the company/science and the clinician/patient. Bridging the gap between innovative therapies and clinical practice, it is their responsibility to translate the complexities of modern innovations to the medical community. Some of the things we see that hold-up Field Medical Teams in their pursuit of this are: • Keeping up with the latest research, clinical trial data, and medical advancements. • Coordinating their engagements with other company departments such as commercial, regulatory, and clinical development to ensure alignment and consistency in messaging and strategy. • Navigating and complying with the compliance requirements for Field Medical engagements. • Communicating complex scientific information to a diverse audience with varying levels of understanding. • Challenges in engaging with an ever-enlarging group of stakeholders, beyond the traditional HCP/KEE target audience. • Establishing trust and long-term relationships with clinicians in an increasingly competitive environment. Do these sound familiar to you? At LUCENT we partner with biopharma organisations to help deliver world-class Field Medical performance. Trust us to develop excellence in your Field Medical teams. #FieldMedical #MedicalExcellence #Pharmaceuticals #BioPharma

7

Join Interchem's upcoming small animal webinar titled "PAX a punch: Navigating Dermatological Therapy of Atopic Dermatitis", with guest speaker Aoife Morrow BVSc, MRCVS, Cert AVP (Derm) and Interchem's Dr. Lauren Popiolek DVM, BSA. Join to win one of two London Vet Show packages, including flights, show tickets & accommodation! This webinar takes place on Wednesday 29th May 2024 from 7:30pm. The webinar will cover the following topics: - Overview of allergic dermatitis - Working up of the allergic patient - The importance of allergy testing - What is macroarray serology testing, and how it impacts the reliability of serum testing? - Improving patient outcomes with allergen specific immunotherapy - Using topical therapy as part of the multi-modal approach to managing allergic patients Click the link below to register: https://bit.ly/PAXWEB24

20